Angelina Jolie’s decision to undergo risk-reducing mastectomy after being tested positive for the BRCA1 gene mutation was one of the longest lasting news stories that affected referrals specific to assessment of breast cancer family history, request for BRCA1/2 testing, and enquiries for risk-reducing mastectomy, especially in the United Kingdom around May 2013 and onward [37]. This evidence concerns the gene BRCA1 and breast carcinoma.